JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB184787

Anti-Caspase-3 antibody [EPR18297]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

3

(2 Reviews)

|

(415 Publications)

Anti-Caspase-3 antibody [EPR18297] (ab184787) is a rabbit monoclonal antibody detecting Caspase-3 in Western Blot, IP, IHC-P. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 220 publications

View Alternative Names

CPP32, CASP3, Caspase-3, CASP-3, Apopain, Cysteine protease CPP32, Protein Yama, SREBP cleavage activity 1, CPP-32, SCA-1

10 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Immunohistochemical analysis of paraffin-embedded Human cervical cancer tissue labeling active and pro Caspase 3 with ab184787 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Nucleus and cytoplasm staining on tumor cells of Human cervix cancer is observed. Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling active and pro Caspase 3 with ab184787 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Nucleus and cytoplasm staining on lymphocytes of tonsil is observed. Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling Caspase-3 with ab184787 at a concentration of 0.05µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.

ab184787 Anti-Caspase-3 antibody [EPR18297] antibody was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)

Immunoprecipitation - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • IP

Supplier Data

Immunoprecipitation - Anti-Caspase-3 antibody [EPR18297] (AB184787)

active and pro Caspase 3 was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate treated with 1uM staurosporine for 4 hours with ab184787 at 1/80 dilution. Western blot was performed from the immunoprecipitate using ab184787 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/1500 dilution.

Lane 1 : HeLa whole cell lysate treated with 1uM staurosporine for 4 hours 10 μg (Input).

Lane 2 : ab184787 IP in HeLa whole cell lysate treated with 1uM staurosporine for 4 hours.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab184787 in HeLa whole cell lysate treated with 1uM staurosporine for 4 hours.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 3 minutes.

All lanes:

Immunoprecipitation - Anti-Caspase-3 antibody [EPR18297] (ab184787)

Predicted band size: 31 kDa

Observed band size: 17 kDa,32 kDa

false

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • WB

Supplier Data

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Blocking/Dilution buffer : 5% NFDM/TBST.

Specificity : interacts with full length pro-Caspase 3 and the p17 subunit.

The Caspase-3 precursor is first cleaved between D175 and S176 to produce the p11 subunit and p20 fragment. Subsequently, the p20 fragment is cleaved between D28 and S29 to generate the p17 subunit (Proc. Natl. Acad. Sci. USA. 93, 7464-7469 - PMID : 8755496).

All lanes:

Western blot - Anti-Caspase-3 antibody [EPR18297] (ab184787) at 1/2000 dilution

Lane 1:

Untreated Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysates at 10 µg

Lane 2:

Jurkat whole cell lysates treated with 1uM staurosporine for 4 hours at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 31 kDa

Observed band size: 17 kDa,32 kDa

false

Exposure time: 1min

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • WB

Lab

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Lane 1 : Wild-type HAP1 cell lysate + Staurosporine (1μM for 4h)
Lane 2 : Wild-type HAP1 cell lysate
Lane 3 : Caspase-3 knockout HAP1 cell lysate + Staurosporine (1μM for 4h)
Lane 4 : Caspase-3 knockout HAP1 cell lysate
Lanes 1 - 4 : Merged signal (red and green). Green - ab184787 observed at 35 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab184787 was shown to recognise pro Caspase 3 when Caspase 3 knockout samples were used, along with additional cross-reactive bands. Wild-type and Caspase 3 knockout samples (± Staurosporine treatment) were subjected to SDS-PAGE. ab184787 and ab8245 (loading control to GAPDH) were diluted to 1/2000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776)
secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Caspase-3 antibody [EPR18297] (ab184787)

Predicted band size: 31 kDa

Observed band size: 32 kDa

false

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • WB

Lab

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Anti-CASP3 antibody [EPR18297] (ab184787) staining at 1/2000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab184787 was shown to bind specifically to CASP3. A band was observed at 35 kDa in treated wild-type HAP1 and HeLa cell lysates with no signal observed at this size in CASP3 knockout HAP1 cell line and a band at a lower molecular weight in the CAPS3 knockout HeLa cell line ab255370 (knockout cell lysate ab263779) which cannot be cleaved to active CASP3. To generate this image, wild-type and CASP3 knockout HAP1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Caspase-3 antibody [EPR18297] (ab184787) at 1/2000 dilution

Lane 1:

Wild-type HAP1 Treated Staurosporine (2 uM, 4h) cell lysate at 20 µg

Lane 2:

CASP3 knockout HAP1 Treated Staurosporine (2 uM, 4h) cell lysate at 20 µg

Lane 3:

Wild-type HAP1 Vehicle Control Staurosporine (0 uM, 4h) cell lysate at 20 µg

Lane 4:

CASP3 knockout HAP1 Vehicle Control Staurosporine (0 uM, 4h) cell lysate at 20 µg

Lane 5:

Wild-type HeLa Treated Staurosporine (2 uM, 4h) cell lysate at 20 µg

Lane 6:

CASP3 knockout HeLa Treated Staurosporine (2 uM, 4h) cell lysate at 20 µg

Lane 7:

Wild-type HeLa Vehicle Control Staurosporine (0 uM, 4h) cell lysate at 20 µg

Lane 8:

CASP3 knockout HeLa Vehicle Control Staurosporine (0 uM, 4h) cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 31 kDa

Observed band size: 35 kDa

false

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • WB

Lab

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as GAPDH loading control. Bands between 27-32kDa represent cleavage of the procaspase at D9 and D28, respectively (PMID : 14567691)

All lanes:

Western blot - Anti-Caspase-3 antibody [EPR18297] (ab184787) at 1/1000 dilution

Lane 1:

Mouse Alzheimer's disease brain tissue lysate at 20 µg

Lane 2:

Mouse brain cancer tissue lysate at 20 µg

Lane 3:

Mouse hippocampus tissue lysate at 20 µg

Lane 4:

Mouse spinal cord tissue lysate at 20 µg

Lane 5:

Mouse cerebellum tissue lysate at 20 µg

Lane 6:

Mouse cerebral cortex tissue lysate at 20 µg

Lane 7:

Mouse hypothalamus tissue lysate at 20 µg

Lane 8:

Mouse heart tissue lysate at 20 µg

Lane 9:

Mouse liver tissue lysate at 20 µg

Lane 10:

Human brain tissue lysate at 20 µg

Lane 11:

Human liver tissue lysate at 20 µg

Lane 12:

Human hypothalamus tissue lysate at 20 µg

Lane 13:

Human heart tissue lysate at 20 µg

Lane 14:

Human cerebellum tissue lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 32 kDa

false

Exposure time: 10s

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • WB

Lab

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Blocking and diluting buffer : 5% NFDM/TBST.

ab184787 recognizes pro-Caspase 3 and unable to detect the active caspases after induction in mouse and rat samples.

All lanes:

Western blot - Anti-Caspase-3 antibody [EPR18297] (ab184787) at 0.7 µg/mL

Lane 1:

Untreated NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg

Lane 2:

NIH/3T3 (Mouse embryonic fibroblast) treated with 1μM Staurosporine for 4 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 31 kDa

Observed band size: 32 kDa

false

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)
  • WB

Lab

Western blot - Anti-Caspase-3 antibody [EPR18297] (AB184787)

Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as GAPDH loading control. Bands between 27-32kDa represent cleavage of the procaspase at D9 and D28, respectively (PMID : 14567691)

All lanes:

Western blot - Anti-Caspase-3 antibody [EPR18297] (ab184787) at 1/1000 dilution

Lane 1:

Rat brain tissue lysate at 20 µg

Lane 2:

Rat hippocampus tissue lysate at 20 µg

Lane 3:

Rat spinal cord tissue lysate at 20 µg

Lane 4:

Rat cerebellum tissue lysate at 20 µg

Lane 5:

Rat cerebral cortex tissue lysate at 20 µg

Lane 6:

Rat hypothalamus tissue lysate at 20 µg

Lane 7:

Rat heart tissue lysate at 20 µg

Lane 8:

Rat liver tissue lysate at 20 µg

Lane 9:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 31 kDa

false

Exposure time: 20s

  • Carrier free

    Anti-Caspase-3 antibody [EPR18297] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR18297

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody recognizes pro-Caspase 3 and potentially cross reacts with active caspases after apoptosis has been induced in wildtype cells and not Caspase 3 knockout cells

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p>The 17 kDa band is the active form of the cleaved caspase 3 (subunit p17).<br>ab184787 recognizes pro-Caspase 3 and unable to detect the active caspases after induction in mouse and rat samples.</p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/80", "IP-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p>The 17 kDa band is the active form of the cleaved caspase 3 (subunit p17).<br>ab184787 recognizes pro-Caspase 3 and unable to detect the active caspases after induction in mouse and rat samples.</p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p>The 17 kDa band is the active form of the cleaved caspase 3 (subunit p17).<br>ab184787 recognizes pro-Caspase 3 and unable to detect the active caspases after induction in mouse and rat samples.</p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

Anti-Caspase-3 antibody [EPR18297] (ab184787) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, IP, WB in human, mouse, rat samples.

Anti-Caspase-3 antibody [EPR18297] (ab184787) has been cited over 223 times in peer reviewed journals and is trusted by the scientific community.

Abcam's high quality manufacturing and validation processes ensure Anti-Caspase-3 antibody [EPR18297] (ab184787) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.

The specificity of Anti-Caspase-3 antibody [EPR18297] (ab184787) has been confirmed by testing in knockout samples.

Anti-Caspase-3 antibody [EPR18297] (ab184787) specifically detects Caspase-3 (UniProt ID: P42574; Molecular weight: 17kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 35338844, PubMed : 35446120, PubMed : 7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed : 10497198, PubMed : 16374543, PubMed : 7596430, PubMed : 7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed : 7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed : 37993714, PubMed : 9334240). Involved in the cleavage of huntingtin (PubMed : 8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed : 21357690). Cleaves DSG2 in response to apoptosis resulting in a loss of full length DSG2 at desmosome cell junctions and subsequent loss of cell-cell adhesion (PubMed : 17559062). Also cleaves JUP in response to apoptosis (PubMed : 17559062). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed : 23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed : 30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed : 35338844, PubMed : 35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed : 23845944, PubMed : 33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed : 36758104, PubMed : 36758106).
See full target information CASP3

Publications (415)

Recent publications for all applications. Explore the full list and refine your search

The Tohoku journal of experimental medicine : PubMed41034038

2025

Acupuncture Ameliorates Cognitive Dysfunction by Modulating the Apoptosis of Hippocampal Neuron in Severe Hand Foot and Mouth Disease Infant Rats Through the p38 MAPK/CREB Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zongtao Wu,Hongjiao Jin,Biqin Shuai,Xiang Zhang,San Wang,Lan Chen,Bo Huang

Regenerative biomaterials 12:rbaf063 PubMed41000195

2025

Functionalized biomimetic nanoparticles are delivered from the nose to the brain for the synergistic targeted treatment of cerebral ischemia/reperfusion injury.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanyuan Wu,Huiyi Feng,Leying Gao,Xinyang Wang,Yue Hu,Xiaofang He,Qianqian Wu,Haolin Liu,Yu Long,Yuyu Fang,Nan Li

MedComm 6:e70355 PubMed40969299

2025

Keratinocyte Autophagy-Mediated Self-Assembling Tetrahedral Framework Nucleic Acid Induces Wound Healing and Reduces Scar Hyperplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Jin,Jia-Jie Li,Zi-Han Tao,Rong-Jia Li,Zi-Liang Zhang,Qing-Song Liu,Zheng-Li Chen,Ji-Qiu Chen,Chen-Ru Wei,Lei Liu,Liang-Liang Zhu,Shi-Hui Zhu,Yun-Feng Lin

Cureus 17:e89688 PubMed40932981

2025

miR-872 Protection Against Renal Ischemia-Reperfusion Injury via Targeting HMOX1.

Applications

Unspecified application

Species

Unspecified reactive species

Jiang Wei,Zhang L Feng,Cheny Y Mao,Huang Xi,Fu Ming,Chen Jun

Mediators of inflammation 2025:4932970 PubMed40918406

2025

Electroacupuncture Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating the Esr1/TAK1-JNK/p38 Signaling Pathway in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaofang Fan,Wei Guo,Xiaodan Yang,Hao Zhang,Bruno Fink,Lingyu Hu,Xiaoguang Wang

Frontiers in pharmacology 16:1600435 PubMed40918528

2025

Gypenoside XLIX inhibiting PI3K/AKT/FOXO1 signaling pathway mediated neuronal mitochondrial autophagy to improve patients with ischemic stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Yonglei Liu,Hongdie Mao,Zhengguang Sha,Jishuai Zhao,Hui Cai,Rong Xi,Zhenzhu Zhao,Xiaoling Yin,Lin Yang,Changyun Liu

Annals of medicine and surgery (2012) 87:5512-5521 PubMed40901091

2025

Electroacupuncture therapy improves cognitive dysfunction after ischemic stroke in Sprague-Dawley rats by adjusting the lncRNA-MEG3/miR-4640-3p axis.

Applications

Unspecified application

Species

Unspecified reactive species

Yun Zhang,Shiqing Gao,Ling Lin,Yongbing Zheng

PLoS neglected tropical diseases 19:e0013443 PubMed40892762

2025

PANoptosis-mediated mechanisms underlying AST elevation in Talaromyces marneffei infection.

Applications

Unspecified application

Species

Unspecified reactive species

Wudi Wei,Baili Zhan,Lixiang Chen,Gang Wang,Xiuli Bao,Xiaotao He,Meng Zhang,Xiaoting Xie,Weihong Huang,Zhiman Xie,Junjun Jiang,Hao Liang,Li Ye

Pharmaceuticals (Basel, Switzerland) 18: PubMed40872544

2025

Pharmacological Investigation of Tongqiao Jiuxin Oil Against High-Altitude Hypoxia: Integrating Chemical Profiling, Network Pharmacology, and Experimental Validation.

Applications

Unspecified application

Species

Unspecified reactive species

Jiamei Xie,Yang Yang,Yuhang Du,Xiaohua Su,Yige Zhao,Yongcheng An,Xin Mao,Menglu Wang,Ziyi Shan,Zhiyun Huang,Shuchang Liu,Baosheng Zhao

Cell & bioscience 15:124 PubMed40877964

2025

Enriched environment inhibits GLT-1 ubiquitination by downregulating SMURF1 to attenuate ischemic brain injury induced excitotoxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Zhang,Wen Liu,Tao Huang,Lingling Liu,Xiuping Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com